Doubt the Chinese (government?) would be (encouraging) investment for only a share price arbitrage of 30/50 cents a share above 94 cents just paid. This could be a strategic acquisition to take medical surgeries and ophthalmic know how into China. Suspect they like what they see in laser cataract surgery and ageing Chinese population. Then looking at levels of $5 a share. Potential long term game changer here.
Ann: Primary Health Care Sale to Jangho Group, page-2
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
